ZIKA VACCINES MARKET ANALYSIS

Leading Companies

Some key players operating in the zika vaccines market are Cerus Corporation, Biken Inc, GlaxoSmithKline plc, Bharat Biotech International Pvt. Ltd, GeneOne Life Science, Inovio Pharmaceuticals, Immunovaccine Inc., NewLink Genetics Corp. and Sanofi S.A. The companies launched various R&D measures and clinical trials to attain immunogenicity against zika virus. In February 2016, Sanofi S.A launched a vaccine research and development project, with the introduction of Dengvaxia (Dengue vaccine) that will aid the company understand the Zika virus and develop an effective vaccine against it. Likewise, Inovio Pharmaceuticals initiated a clinical study of zika vaccine (GLS-5700) in Puerto Rico in August 2016. This trial may provide a potential push to Inovio’s vaccine if positive results are reported as there was a rapid progression of zika outbreak in Puerto Rico at that time. This could benefit the trial in assessing true efficacy and safety of the vaccine. Rapid progression in clinical trials and approval would augment the zika vaccines market growth.